Funder
Science and Engineering Research Board, India
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Arunasree KM, Roy KR, Anilkumar K, Aparna A, Reddy GV, Reddanna P. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Leuk Res. 2008;32:855–64.
2. Chandrasekhar J, Mehran R. The role of genetics in acute coronary syndrome. Cardiovascular diseases: genetic susceptibility, environmental factors and their interaction. London: JAcademic Press; 2016. p. 25–55.
3. Daghistani M, Marin D, Khorashad JS, Wang L, Philippa CM, Paliompeis C, et al. EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors. Blood. 2010;116:6014–7.
4. Diamond JM, Melo JV. Mechanisms of resistance to BCR-ABL kinase inhibitors. Leuk Lymphoma. 2011;52:12–22.
5. Dreos R, Ambrosini G, Groux R, Perier RC, Bucher P. The eukaryotic promoter database in its 30th year: focus on non-vertebrate organisms. Nucleic Acids Res. 2017;45:D51–5.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献